Putaminal dopamine modulates movement motivation in Parkinson’s disease

Magdalena Banwinkler,Verena Dzialas,Lionel Rigoux,Adrian L. Asendorf,Hendrik Theis,Kathrin Giehl,Marc Tittgemeyer,Merle C. Hoenig,Thilo van Eimeren
DOI: https://doi.org/10.1101/2024.03.15.585221
2024-03-17
Abstract:The relative inability to produce effortful movements (akinesia) is the most specific motor sign of Parkinson’s disease. The motor motivation hypothesis suggests that akinesia may not reflect a deficiency in motor control , but a deficiency in cost-benefit considerations for motor effort. For the first time, we investigated the quantitative effect of dopamine depletion on the motivation of motor effort in Parkinson’s disease. A total of 21 patients with Parkinson’s disease and 26 healthy controls were included. An incentivized force task was used to capture the amount of effort participants were willing to invest for different monetary incentive levels and dopamine transporter depletion in the bilateral putamen was assessed. Our results demonstrate that patients with Parkinson’s disease applied significantly less grip force than healthy controls, especially for low incentive levels. Congruously, decrease of motor effort with greater loss of putaminal dopaminergic terminals was most pronounced for low incentive levels. This signifies that putaminal dopamine is most critical to motor effort when the trade-off with the benefit is poor. Taken together, we provide direct evidence that the reduction of effortful movements in Parkinson’s disease depends on motivation and that this effect is associated with putaminal dopaminergic degeneration.
Neuroscience
What problem does this paper attempt to address?
The problem this paper attempts to address is the motivational deficit in effortful movement observed in patients with Parkinson's disease (PD) and explores the relationship between this deficit and the loss of dopaminergic neurons in the caudate nucleus. Specifically, the paper investigates the impact of caudate nucleus dopaminergic terminal loss on the effortful movement of Parkinson's disease patients under different levels of incentive. The study found that the grip strength of Parkinson's disease patients at lower incentive levels was significantly lower than that of healthy controls, and this difference was related to the extent of dopaminergic terminal loss in the caudate nucleus. This suggests that dopamine in the caudate nucleus is particularly important when the trade-off between effort and reward is poor. Additionally, the study found that the fatigue effect in Parkinson's disease patients was more pronounced than in healthy controls, but this effect was not related to the loss of dopaminergic terminals in the caudate nucleus. Overall, the paper provides direct evidence that the reduced movement in Parkinson's disease patients is related to motivation, and this effect is associated with dopaminergic degeneration in the caudate nucleus.